About: COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 30 March 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu en marzu de 2020 (ast) im März 2020 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 30 March 2020 (en) наукова стаття, опублікована 30 березня 2020 (uk)
publication date	wds:Q91638688-CC06F8F9-D921-4A89-96E6-AC418A0EBCD8
publication date	2020-03-30 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q91638688-64492778-AC7B-4283-83C0-FAC3287304DA
language of work or name	English
cites work	wds:Q91638688-024F5117-4085-4738-A2F5-CF2B421008C0 wds:Q91638688-081203B5-6780-4875-AB95-873FE8146F43 wds:Q91638688-0F0D4DCF-29EB-4211-B4A7-975B1C928ECA wds:Q91638688-2F618254-45CA-40A3-B568-108ACE593AD4 wds:Q91638688-69D83B52-F462-403D-AC83-7318C21C9682 wds:Q91638688-70776686-541B-427B-88A5-9ED806C1B2CE wds:Q91638688-861ED43C-311F-4399-B027-FE324A58120D wds:Q91638688-887A6C19-A5A9-426B-BC50-5288BD533F1A wds:Q91638688-ABB3F5BC-ADFD-40B9-9201-8FCBAD067F28 wds:Q91638688-BC9C251B-CC53-42ED-BAFD-F7BE6EAB22AC wds:Q91638688-C16AA9EA-B98B-4943-9694-D846FBA294DA wds:Q91638688-C2809BE6-8842-41A6-8FDD-2D2B0D3A18F1 wds:Q91638688-E472D244-99B3-489D-923F-C83512B88E47
cites work	Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. The management of coronavirus infections with particular reference to SARS. Severe acute respiratory syndrome: clinical and laboratory manifestations Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells Indomethacin has a potent antiviral activity against SARS coronavirus Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Drug treatment options for the 2019-new coronavirus (2019-nCoV) Decoding the enigma of antiviral crisis: Does one target molecule regulate all? [A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it]. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome
author name string	wds:Q91638688-045C6DDA-7467-4C01-B4D5-20FA206FD710 wds:Q91638688-1EBD83A9-7E00-4C88-A93A-E54629221CBB wds:Q91638688-4A14EBCF-DF06-4DE5-A2EB-5D110A7B42F7 wds:Q91638688-A7BB6A37-785F-40FA-B8A9-3EDB950664C5
author name string	Mieke Van Hemelrijck Anne Rigg Beth Russell Charlotte Moss
rdfs:label	COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (en) COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (nl)
skos:prefLabel	COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (en) COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (nl)
name	COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (en) COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (nl)
title	wds:Q91638688-0566C9EF-42DA-413D-8080-6FC326AAF281
title	COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? (en)
page(s)	wds:Q91638688-4E687C9E-D273-4E16-B4A8-18715A66E084
page(s)	1023
instance of	wds:Q91638688-39A50B94-8563-423D-B752-77C63C153BFF
instance of	scholarly article
main subject	wds:Q91638688-01A34744-A362-40EE-8F93-1A802D9CB08C wds:Q91638688-B3B8B2DC-6E2E-4432-A79D-8ECC8B83881C
main subject	SARS-CoV-2 COVID-19 mortality
PubMed ID	wds:Q91638688-C80B699B-C1E3-451F-817B-FB86E1476B13
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32256706
PubMed ID	32256706
published in	wds:Q91638688-12B65263-3E0A-4A14-91C4-35A8161B1B7C
published in	Ecancermedicalscience
volume	wds:Q91638688-F80886C9-557C-44C6-AAB5-78EF122CE27B
volume	14
DOI	wds:Q91638688-E46BCBCD-5969-433D-A38F-1DCD3FED75C1
DOI	http://dx.doi.org/10.3332/ECANCER.2020.1023
DOI	10.3332/ECANCER.2020.1023
Semantic Scholar corpus ID	wds:Q91638688-1150D4C5-E347-43AF-901F-7221E8DAE183
Semantic Scholar corpus ID	214716607
Dimensions Publication ID	wds:Q91638688-A0E01690-CCDC-4BAE-B968-D20ABB82DA2A
Dimensions Publication ID	1125993717
PMCID	wds:Q91638688-7828035E-D072-4B4D-871F-67F1EED465E5
PMCID	7105332
COVIDWHO ID	wds:Q91638688-DDFF8AED-6241-46E5-86EA-701E633D20A8 wds:Q91638688-e60969c1-3f74-4eed-ace3-66d01cc3dfa4
COVIDWHO ID	covidwho-32256706 covidwho-44723
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91638688
is cites work of	Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19? Immunomodulatory Drugs in the Management of SARS-CoV-2 Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic] Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective Managing rheumatoid arthritis during COVID-19 Interventional oncology at the time of COVID-19 pandemic: Problems and solutions Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Overview of Covid-19; its prevention and management in the light of Unani medicine Pharmacists' readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge Maternal Fetal Surgery During the COVID-19 Pandemic Nanoceria as a possible agent for the management of COVID-19 Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software